Skip to content

PPCB

Propanc Biopharma, Inc.

NASDAQ · Healthcare · Biotechnology · AU

$1.01
−0.98%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-31.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 23, 2023ZELINGER JOSEF · directorA-Award15,000,000$0.01
Aug 20, 2021Kenyon Julian Norman · director, officer: Chief Scientific OfficerA-Award3,420,000$0.00
Aug 20, 2021Nathanielsz James Andrew · director, officer: CEO/CFOA-Award5,928,000$0.00
Aug 20, 2021Nathanielsz James Andrew · director, officer: CEO/CFOA-Award2,800,000$0.00
May 22, 2019Kenyon Julian Norman · director, officer: Chief Scientific OfficerA-Award9,750,000$0.01
May 17, 2019Nathanielsz James Andrew · director, officer: CEO, Acting CFO, ChairmanA-Award19,500,000$0.01
Sep 27, 2016Nathanielsz James Andrew · director, officer: CEO, CFO, Secretary, TreasurerA-Award71,500,000$0.03
Sep 27, 2016Kenyon Julian Norman · directorA-Award71,500,000$0.03
Jan 13, 2015Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerSale250,000$0.20
Jan 13, 2015Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerSale5,000$0.20
Jan 13, 2015Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerSale5,500$0.20
Jan 13, 2015Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerSale15,000$0.20
Jan 13, 2015Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerSale55,000$0.09
Jan 13, 2015Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerA-Award500,000$0.00
Aug 24, 2012Nathanielsz James Andrew · director, 10 percent owner, officer: Chief Executive OfficerPurchase250,000$0.20

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 23, 2023